- Home
- CATX vs PSF Comparison
CATX vs PSF Comparison
Compare CATX & PSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATX
- PSF
- Stock Information
- Founded
- CATX 1983
- PSF 2010
- Country
- CATX United States
- PSF United States
- Employees
- CATX N/A
- PSF N/A
- Industry
- CATX Medical/Dental Instruments
- PSF Investment Managers
- Sector
- CATX Health Care
- PSF Finance
- Exchange
- CATX Nasdaq
- PSF Nasdaq
- Market Cap
- CATX 239.0M
- PSF 236.8M
- IPO Year
- CATX N/A
- PSF N/A
- Fundamental
- Price
- CATX $3.67
- PSF $20.53
- Analyst Decision
- CATX Strong Buy
- PSF
- Analyst Count
- CATX 11
- PSF 0
- Target Price
- CATX $12.90
- PSF N/A
- AVG Volume (30 Days)
- CATX 954.5K
- PSF 25.0K
- Earning Date
- CATX 08-13-2025
- PSF 01-01-0001
- Dividend Yield
- CATX N/A
- PSF 7.69%
- EPS Growth
- CATX N/A
- PSF N/A
- EPS
- CATX N/A
- PSF N/A
- Revenue
- CATX $1,471,000.00
- PSF N/A
- Revenue This Year
- CATX N/A
- PSF N/A
- Revenue Next Year
- CATX $11.99
- PSF N/A
- P/E Ratio
- CATX N/A
- PSF N/A
- Revenue Growth
- CATX N/A
- PSF N/A
- 52 Week Low
- CATX $1.60
- PSF $16.00
- 52 Week High
- CATX $16.55
- PSF $20.19
- Technical
- Relative Strength Index (RSI)
- CATX 44.88
- PSF 67.03
- Support Level
- CATX $3.88
- PSF $20.42
- Resistance Level
- CATX $4.28
- PSF $20.61
- Average True Range (ATR)
- CATX 0.27
- PSF 0.11
- MACD
- CATX -0.08
- PSF 0.02
- Stochastic Oscillator
- CATX 2.32
- PSF 86.44
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About PSF Cohen & Steers Select Preferred and Income Fund Inc.
Cohen & Steers Select Preferred and Income Fund Inc is a diversified, closed-end investment company. The Fund's primary investment objective is high current income with capital appreciation as its secondary objective. The Fund invests at least of its Managed Assets in preferred and other income securities issued by U.S. and non-U.S. companies.